Search - tctmd.com

Displaying 21 - 40 of 40

Sort: Relevancy | Date

Presentation ESC 2017

Guidelines for the Management of Valvular Heart Disease

Presenter: Helmut Baumgartner

August 29, 2017

News Conference News ESC 2017

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Shelley Wood

August 27, 2017

News Conference News ESC 2016

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Todd Neale

September 02, 2016

Presentation ESC 2015

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Presenter: Gregg W. Stone

August 30, 2015

Presentation ESC 2014

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Presenter: Biner S. Finkelstein

September 03, 2014

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

Presentation ESC 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presenter: Eric Van Belle

September 02, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Caitlin E. Cox

August 31, 2014

News Conference News ESC 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Todd Neale

August 31, 2014

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

Presentation ESC 2013

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

Presenter: Brian R. Lindman

September 03, 2013

News Conference News ESC 2013

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Caitlin E. Cox

September 02, 2013

News Conference News ESC 2012

French, European Registries Add International Flavor to TAVR Assessment

August 29, 2012

News Conference News ESC 2012

TAVR Improves Quality of Life, Reduces Hospitalization in German Registry

Yael L. Maxwell

August 28, 2012

Presentation ESC 2012

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Presenter: Markus Ferrari

August 28, 2012

News Conference News ESC 2012

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Caitlin E. Cox

August 28, 2012

News Conference News ESC 2012

Registries Show Strides for Transcatheter Valve Treatments in Europe

Caitlin E. Cox

August 27, 2012

News Conference News ESC 2012

Predictors of Aortic Regurgitation After TAVR Delineated

August 26, 2012

Advertisement

Guidelines for the Management of Valvular Heart Disease

European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts

Valve Thrombosis After TAVR Linked to Larger Device Size, Lack of Warfarin Therapy

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

FRANCE2: Registry Shows Positive Outcomes for TAVR in High-Risk Diabetic Patients

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Transcatheter versus Surgical Aortic Valve Replacement in Patients with Diabetes and Severe Aortic Stenosis at High Risk for Surgery: PARTNER I, High-risk Cohort

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

French, European Registries Add International Flavor to TAVR Assessment

TAVR Improves Quality of Life, Reduces Hospitalization in German Registry

Early Experience With the JenaValve™ Transapical Aortic Valve Implantation System

Dedicated Transapical TAVR Device Shows Promise in Premarket Clinical Research

Registries Show Strides for Transcatheter Valve Treatments in Europe

Predictors of Aortic Regurgitation After TAVR Delineated

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content